Literature DB >> 19318564

Association between chronic atrophic gastritis and serum antibodies to 15 Helicobacter pylori proteins measured by multiplex serology.

Lei Gao1, Melanie N Weck, Angelika Michel, Michael Pawlita, Hermann Brenner.   

Abstract

Infection with Helicobacter pylori is a major risk factor for chronic atrophic gastritis (CAG), a precursor lesion of intestinal gastric cancer. The pathogenicity of the bacterium is thought to play an important role in determining the extent and severity of clinical outcome. We aimed to assess the associations between CAG and the serostatus of antibodies to 15 H. pylori proteins. The analyses were based on 534 cases with serologically defined CAG and 1,068 age-matched and sex-matched controls participating in a population-based study conducted in Saarland, Germany among 9,953 men and women ages 50 to 74 years. A newly developed H. pylori multiplex serology method was used to detect antibodies specific to 15 H. pylori antigens. Significant associations were observed between seropositivity for all 15 specific antibodies and the presence of CAG. Exclusion of severe cases, who might have lost the infection in the course of CAG progression, substantially increased the observed associations. In H. pylori-seropositive subjects, cytotoxin-associated gene A (CagA), vacuolating toxin (VacA), helicobacter cysteine-rich protein C (HcpC), and the chaperonin GroEL were identified as independent virulence factors for CAG with adjusted odds ratios (95% confidence interval) of 3.52 (2.01-6.10), 3.19 (1.44-7.05), 4.03 (1.53-10.65), and 2.65 (1.06-6.62), respectively; the simultaneous presence of all four independent virulence factors was associated with an 18-fold risk of CAG. In conclusion, HcpC and GroEL were identified as new independent virulence factors, and in combination with the established virulence factors, CagA and VacA, were strongly associated with CAG.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19318564     DOI: 10.1158/0008-5472.CAN-08-3477

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  31 in total

1.  Serological response to Helicobacter pylori infection among Latin American populations with contrasting risks of gastric cancer.

Authors:  M Constanza Camargo; Mauricio Beltran; Carlos J Conde-Glez; Paul R Harris; Angelika Michel; Tim Waterboer; Astrid Carolina Flórez; Javier Torres; Catterina Ferreccio; Joshua N Sampson; Michael Pawlita; Charles S Rabkin
Journal:  Int J Cancer       Date:  2015-07-16       Impact factor: 7.396

2.  Recognition of host proteins by Helicobacter cysteine-rich protein C.

Authors:  Bernd Roschitzki; Stefan Schauer; Peer R E Mittl
Journal:  Curr Microbiol       Date:  2011-07-07       Impact factor: 2.188

3.  Prospective study of Helicobacter pylori antigens and gastric noncardia cancer risk in the nutrition intervention trial cohort.

Authors:  Gwen Murphy; Neal D Freedman; Angelika Michel; Jin-Hu Fan; Philip R Taylor; Michael Pawlita; You-Lin Qiao; Han Zhang; Kai Yu; Christian C Abnet; Sanford M Dawsey
Journal:  Int J Cancer       Date:  2015-05-05       Impact factor: 7.396

4.  Physiological levels of glucose induce membrane vesicle secretion and affect the lipid and protein composition of Yersinia pestis cell surfaces.

Authors:  Anna M Kolodziejek; Allan B Caplan; Gregory A Bohach; Andrzej J Paszczynski; Scott A Minnich; Carolyn J Hovde
Journal:  Appl Environ Microbiol       Date:  2013-05-17       Impact factor: 4.792

5.  Association of seropositivity to Helicobacter species and biliary tract cancer in the ATBC study.

Authors:  Gwen Murphy; Angelika Michel; Philip R Taylor; Demetrius Albanes; Stephanie J Weinstein; Jarmo Virtamo; Dominick Parisi; Kirk Snyder; Julia Butt; Katherine A McGlynn; Jill Koshiol; Michael Pawlita; Gabriel Y Lai; Christian C Abnet; Sanford M Dawsey; Neal D Freedman
Journal:  Hepatology       Date:  2014-07-30       Impact factor: 17.425

6.  Education, marital status, and risk of hip fractures in older men and women: the CHANCES project.

Authors:  V Benetou; P Orfanos; D Feskanich; K Michaëlsson; U Pettersson-Kymmer; L A Ahmed; A Peasey; A Wolk; H Brenner; M Bobak; T Wilsgaard; B Schöttker; K-U Saum; A Bellavia; F Grodstein; E Klinaki; E Valanou; E-M Papatesta; P Boffetta; A Trichopoulou
Journal:  Osteoporos Int       Date:  2015-03-28       Impact factor: 4.507

7.  Epstein-Barr Virus Antibody Titers Are Not Associated with Gastric Cancer Risk in East Asia.

Authors:  Matthew G Varga; Hui Cai; Tim Waterboer; Gwen Murphy; Taichi Shimazu; Phil R Taylor; You-Lin Qiao; Sue K Park; Keun-Young Yoo; Sun Ha Jee; Eo Rin Cho; Jeongseon Kim; Christian C Abnet; Shoichiro Tsugane; Qiuyin Cai; Wei Zheng; Michael Pawlita; Xiao-Ou Shu; Meira Epplein
Journal:  Dig Dis Sci       Date:  2018-06-08       Impact factor: 3.199

8.  Multiplex H. pylori Serology and Risk of Gastric Cardia and Noncardia Adenocarcinomas.

Authors:  Ramin Shakeri; Reza Malekzadeh; Dariush Nasrollahzadeh; Michael Pawlita; Michael Pawilta; Gwen Murphy; Farhad Islami; Masoud Sotoudeh; Angelika Michel; Arash Etemadi; Tim Waterboer; Hossein Poustchi; Paul Brennan; Paolo Boffetta; Sanford M Dawsey; Farin Kamangar; Christian C Abnet
Journal:  Cancer Res       Date:  2015-09-17       Impact factor: 12.701

9.  Low vitamin B12 increases risk of gastric cancer: A prospective study of one-carbon metabolism nutrients and risk of upper gastrointestinal tract cancer.

Authors:  Eugenia H Miranti; Rachael Stolzenberg-Solomon; Stephanie J Weinstein; Jacob Selhub; Satu Männistö; Philip R Taylor; Neal D Freedman; Demetrius Albanes; Christian C Abnet; Gwen Murphy
Journal:  Int J Cancer       Date:  2017-06-21       Impact factor: 7.396

10.  Anti-Helicobacter pylori Antibody Profiles in Epstein-Barr virus (EBV)-Positive and EBV-Negative Gastric Cancer.

Authors:  M Constanza Camargo; Kyoung-Mee Kim; Keitaro Matsuo; Javier Torres; Linda M Liao; Douglas R Morgan; Angelika Michel; Tim Waterboer; Jovanny Zabaleta; Ricardo L Dominguez; Yasushi Yatabe; Sung Kim; Erick R Rocha-Guevara; Jolanta Lissowska; Michael Pawlita; Charles S Rabkin
Journal:  Helicobacter       Date:  2015-08-07       Impact factor: 5.753

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.